Works matching DE "DRUG therapy for schizophrenia"

Results: 1770

Randomized clinical trial of a digital medication system to enhance adherence in patients with severe mental disorders.

Published in:

NPJ Digital Medicine, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s41746-025-01748-2

By:

Zhou, Jia;
Zhai, Qian;
Qi, Han;
Jin, Xiaolei;
Xiao, Cunli;
Li, Wenxiu;
Song, Junwei;
Feng, Lei;
Wang, Haibo;
Dong, Chengcheng;
Yu, Zibo;
Feng, Yuan;
Wang, Gang;
Yan, Fang

Publication type:

Article

Factors related to the treatment of patients with schizophrenia and other mental health problems in the setting of medical illness.

Published in:

2025

By:

Koenig, Harold G.

Publication type:

Editorial

Effects of six antipsychotic drug treatment regimens on short-term heart rate variability in patients with schizophrenia.

Published in:

International Journal of Psychiatry in Medicine, 2025, v. 60, n. 4, p. 363, doi. 10.1177/00912174241293650

By:

Huang, Lifen;
Wei, Chaoyang;
Qin, Qinghua

Publication type:

Article

Psychotropic medication and hepatobiliary health: Ultrasound observations on patients with schizophrenia.

Published in:

International Journal of Psychiatry in Medicine, 2025, v. 60, n. 4, p. 395, doi. 10.1177/00912174241280510

By:

Yue, Linlin;
Sun, Linlin;
Li, Nan

Publication type:

Article

Real‐world usage of paliperidone palmitate injection.

Published in:

Brown University Psychopharmacology Update, 2025, v. 36, n. 7, p. 2, doi. 10.1002/pu.31322

By:

Lam, Y. W. Francis

Publication type:

Article

Xanomeline/Trospium Combination for Schizophrenia: Treatment Considerations for Older Adults.

Published in:

Journal of Gerontological Nursing, 2025, v. 51, n. 6, p. 7, doi. 10.3928/00989134-20250509-03

By:

English, Clayton;
Bergeron, Kaela;
Mike, Leigh Ann

Publication type:

Article

Patient Information Sheet.

Published in:

Brown University Child & Adolescent Psychopharmacology Update, 2025, v. 27, n. 6, p. 9, doi. 10.1002/cpu.30981

By:

Knopf, Alison

Publication type:

Article

Erythromycin-Induced Psychotic Decompensation in a Patient Affected by Paranoid Schizophrenic Psychosis.

Published in:

Klinik Psikofarmakoloji Bulteni, 2014, v. 24, n. 4, p. 368, doi. 10.5455/bcp.20140802124414

By:

Šakić, Branislav Ostoja;
Babović, Sinisa Svetozar;
Gajić, Zoran Milan

Publication type:

Article

Effects of a Psychosocial Rehabilitation Program in Addition to Medication in Schizophrenic Patients: A Controlled Study.

Published in:

Klinik Psikofarmakoloji Bulteni, 2014, v. 24, n. 4, p. 360, doi. 10.5455/bcp.20140701074403

By:

Arslan, Mehtap;
Kurt, Erhan;
Eryildiz, Derya;
Yazici, Ayla;
Can, Aylin;
Emul, Murat

Publication type:

Article

Cognitive, Work and Social Outcomes in Fully Recovered First-Episode Schizophrenia: On and Off Antipsychotic Medication.

Published in:

Psychiatry: Interpersonal & Biological Processes, 2019, v. 82, n. 1, p. 42, doi. 10.1080/00332747.2018.1550735

By:

Fu, Susie;
Czajkowski, Nikolai;
Torgalsbøen, Anne-Kari

Publication type:

Article

How Do Patients With Schizophrenia and Their Families Learn About the Diagnosis?

Published in:

Psychiatry: Interpersonal & Biological Processes, 2018, v. 81, n. 3, p. 283, doi. 10.1080/00332747.2018.1443676

By:

Amsalem, Doron;
Hasson-Ohayon, Ilanit;
Gothelf, Doron;
Roe, David

Publication type:

Article

Predictive Role of Serotonin Receptor (5HTR2A) and Dopamine Receptor (DRD2) gene polymorphisms in risperidone-induced weight gain and hyperprolactinemia in patients with schizophrenia.

Published in:

European Journal of Clinical Pharmacology, 2025, v. 81, n. 6, p. 899, doi. 10.1007/s00228-025-03835-5

By:

Goud, Alladi Charanraj;
Rajkumar, Ravi Philip;
Shewade, Deepak Gopal;
Goenka, Luxitaa;
Srinivasamurthy, Suresh Kumar

Publication type:

Article

Novel pharmaceutical treatment approaches for schizophrenia: a systematic literature review.

Published in:

European Journal of Clinical Pharmacology, 2025, v. 81, n. 4, p. 525, doi. 10.1007/s00228-025-03809-7

By:

Jarab, Anan;
Al-Qerem, Walid;
Khdour, Adam;
Awadallah, Heba;
Mimi, Yousef;
Khdour, Maher

Publication type:

Article

Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 8, p. 1181, doi. 10.1007/s00228-024-03690-w

By:

Yang, Xiding;
Yan, Qiangyong;
Yang, Lingfeng;
Li, Jingjing;
Fan, Xiao;
Chen, Jindong;
Wu, Haishan;
Yang, Yongyu;
Zhu, Ronghua;
Fang, Pingfei

Publication type:

Article

Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 6, p. 839, doi. 10.1007/s00228-024-03655-z

By:

Hole, Kristine;
Lorentsen, Silje K;
Nordby, Karoline L;
Slettvik, Marie;
Sørum, Ida TG;
Molden, Espen;
Haslemo, Tore

Publication type:

Article

Therapeutic drug monitoring as an essential tool to ensure clozapine efficacy and prevent its toxicity in smokers: a case report.

Published in:

2023

By:

Yéléhé-Okouma, Mélissa;
Charrois-Sciaudeau, Sophie;
Tyvaert, Louise;
Bertoni, Nadine;
Gambier, Nicolas

Publication type:

Letter to the Editor

Correction to: An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 6, p. 939, doi. 10.1007/s00228-020-03071-z

By:

Wong, Dean F.;
Raoufinia, Arash;
Bricmont, Patricia;
Brašić, James R.;
McQuade, Robert D.;
Forbes, Robert A.;
Kikuchi, Tetsuro;
Kuwabara, Hiroto

Publication type:

Article

Add-on pharmacotherapy for patients with first-episode schizophrenia: a clinical perspective.

Published in:

2021

By:

Ng, Qin Xiang;
Chong, Joyce Wei Xin;
Chee, Kuan Tsee

Publication type:

Letter to the Editor

An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 5, p. 717, doi. 10.1007/s00228-020-03021-9

By:

Wong, Dean F.;
Raoufinia, Arash;
Bricmont, Patricia;
Brašić, James R.;
McQuade, Robert D.;
Forbes, Robert A.;
Kikuchi, Tetsuro;
Kuwabara, Hiroto

Publication type:

Article

Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 711, doi. 10.1007/s00228-020-02830-2

By:

Puranen, Arto;
Koponen, Marjaana;
Tanskanen, Antti;
Tiihonen, Jari;
Taipale, Heidi

Publication type:

Article

Insulin resistance induced by olanzapine and other second-generation antipsychotics in Chinese patients with schizophrenia: a comparative review and meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 12, p. 1621, doi. 10.1007/s00228-019-02739-5

By:

Yu, Liangyu;
Wu, Sanlan;
Deng, Yahui;
Lei, Juan;
Yu, Lixiu;
Li, Weiyong

Publication type:

Article

Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 289, doi. 10.1007/s00228-018-2595-1

By:

Ghaderi, Amir;
Bussu, Anna;
Tsang, Catherine;
Jafarnejad, Sadegh

Publication type:

Article

Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 10, p. 1215, doi. 10.1007/s00228-018-2498-1

By:

Ribeiro, Esther Letícia Amorim;
de Mendonça Lima, Tácio;
Vieira, Marcio Eduardo Bergamini;
Storpirtis, Sílvia;
Aguiar, Patricia Melo

Publication type:

Article

Determination of plasma concentration reference ranges for oral aripiprazole, olanzapine, and quetiapine.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 5, p. 593, doi. 10.1007/s00228-018-2419-3

By:

Korell, Julia;
Green, Bruce;
Rae, Allan;
Remmerie, Bart;
Vermeulen, An

Publication type:

Article

Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 12, p. 1433, doi. 10.1007/s00228-014-1762-2

By:

Misiak, Błażej;
Frydecka, Dorota;
Łaczmański, Łukasz;
Ślęzak, Ryszard;
Kiejna, Andrzej

Publication type:

Article

Risperidone metabolic ratio as a biomarker of individual CYP2D6 genotype in schizophrenic patients.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 6, p. 695, doi. 10.1007/s00228-014-1664-3

By:

Mannheimer, Buster;
Holm, Johan;
Koukel, Larissa;
Bertilsson, Leif;
Ösby, Urban;
Eliasson, Erik

Publication type:

Article

Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 2, p. 127, doi. 10.1007/s00228-013-1600-y

By:

Désaméricq, G.;
Schurhoff, F.;
Meary, A.;
Szöke, A.;
Macquin-Mavier, I.;
Bachoud-Lévi, A.;
Maison, P.

Publication type:

Article

Newer antipsychotics and upcoming molecules for schizophrenia.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 8, p. 1497, doi. 10.1007/s00228-013-1498-4

By:

George, Melvin;
Amrutheshwar, Radhika;
Rajkumar, Ravi;
Kattimani, Shivanand;
Dkhar, Steven

Publication type:

Article

Zotepine-related myopathy in a patient with schizophrenia.

Published in:

2013

By:

Chen, I-Ming;
Hsieh, Ming;
Hwang, Tzung-Jeng;
Liu, Chen-Chung

Publication type:

Letter

Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 12, p. 1647, doi. 10.1007/s00228-012-1298-2

By:

Conti, Valentino;
Lora, Antonio;
Cipriani, Andrea;
Fortino, Ida;
Merlino, Luca;
Barbui, Corrado

Publication type:

Article

Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 6, p. 951, doi. 10.1007/s00228-011-1189-y

By:

Plowchalk, David;
Rowland Yeo, Karen

Publication type:

Article

IMPACT OF PSYCHOEDUCATIONAL GROUPS FOR CAREGIVERS ON THE PSYCHIATRIC SYMPTOMS OF PATIENTS WITH SCHIZOPHRENIA.

Published in:

Journal of Urmia Nursing & Midwifery Faculty (2228-6411), 2013, v. 11, n. 2, p. 1

By:

Shaygan, M.;
Sharif, F.

Publication type:

Article

Side Effects of Clozapine Treatment in Patients with Schizophrenia and Schizoaffective Disorder and Their Role in the Discontinuation of Treatment.

Published in:

Bosphorus Medical Journal / Boğaziçi Tıp Dergisi, 2023, v. 10, n. 1, p. 32, doi. 10.14744/bmj.2022.59254

By:

Taşdelen, Rümeysa;
Kaya, Hatice;
Üçok, Alp

Publication type:

Article

Primary care contact, clinical management, and suicide risk following discharge from inpatient mental health care: a case-control study.

Published in:

BJGP Open, 2024, v. 8, n. 4, p. 1, doi. 10.3399/BJGPO.2023.0165

By:

Musgrove, Rebecca;
Carr, Matthew J;
Kapur, Nav;
Chew-Graham, Carolyn A;
Mughal, Faraz;
Ashcroft, Darren M;
Webb, Roger T

Publication type:

Article

Physician Experiences With and Perspectives on Clozapine Prescribing.

Published in:

JAMA Network Open, 2025, v. 8, n. 2, p. e2459311, doi. 10.1001/jamanetworkopen.2024.59311

By:

Sarpatwari, Ameet;
Lu, Zhigang;
Russo, Massimiliano;
Zakoul, Heidi;
Lee, Su Been;
Toyserkani, Gita A.;
Zhou, Esther H.;
LaCivita, Cynthia;
Hyatt Hawkins Shaw, Katherine;
Dal Pan, Gerald J.;
Kesselheim, Aaron S.

Publication type:

Article

Medication Exposure and Mortality in Patients With Schizophrenia.

Published in:

JAMA Network Open, 2024, v. 7, n. 11, p. e2447137, doi. 10.1001/jamanetworkopen.2024.47137

By:

Brodeur, Sébastien;
Chiu, Yohann M.;
Courteau, Josiane;
Dorais, Marc;
Oliver, Dominic;
Stip, Emmanuel;
Fleury, Marie-Josée;
Roy, Marc-André;
Vanasse, Alain;
Lesage, Alain;
Leclerc, Jacinthe

Publication type:

Article

Comparative Effectiveness of Antipsychotics in Patients With Schizophrenia Spectrum Disorder.

Published in:

JAMA Network Open, 2024, v. 7, n. 10, p. e2438358, doi. 10.1001/jamanetworkopen.2024.38358

By:

Hamina, Aleksi;
Taipale, Heidi;
Lieslehto, Johannes;
Lähteenvuo, Markku;
Tanskanen, Antti;
Mittendorfer-Rutz, Ellenor;
Tiihonen, Jari

Publication type:

Article

Three-Year Outcomes of 6-Month Paliperidone Palmitate in Adults With Schizophrenia: An Open-Label Extension Study of a Randomized Clinical Trial.

Published in:

JAMA Network Open, 2024, v. 7, n. 7, p. e2421495, doi. 10.1001/jamanetworkopen.2024.21495

By:

Correll, Christoph U.;
Johnston, Karen;
Turkoz, Ibrahim;
Gray, Jason;
Sun, Liping;
Doring, Monica;
Sajatovic, Martha

Publication type:

Article

"My Body Changed a Lot After Taking Medication. I'm Trying to Hide It but..." A Qualitative Exploration of Body Image Experiences of Women Living With Schizophrenia.

Published in:

International Journal of Mental Health Nursing, 2025, v. 34, n. 1, p. 1, doi. 10.1111/inm.13475

By:

Şengün İnan, Figen;
Tuncer, Gülsüm Zekiye;
Çetinkaya Duman, Zekiye

Publication type:

Article

The effect of long‐acting injectable antipsychotic medications compared with oral antipsychotic medications among people with schizophrenia: A systematic review and meta‐analysis.

Published in:

International Journal of Mental Health Nursing, 2022, v. 31, n. 3, p. 469, doi. 10.1111/inm.12964

By:

Okoli, Chizimuzo T.C.;
Kappi, Amani;
Wang, Tianyi;
Makowski, Andrew;
Cooley, Andrew T.

Publication type:

Article

An assessment of periodontal health in patients with schizophrenia and taking antipsychotic medication.

Published in:

International Journal of Dental Hygiene, 2013, v. 11, n. 2, p. 78, doi. 10.1111/j.1601-5037.2012.00558.x

By:

Eltas, A;
Kartalcı, Ş;
Eltas, ŞD;
Dündar, S;
Uslu, MO

Publication type:

Article

Enhancing Medication Adherence Among Patients With Schizophrenia and Schizoaffective Disorder: Mobile App Intervention Study.

Published in:

SAGE Open Nursing, 2023, p. 1, doi. 10.1177/23779608231197269

By:

Al Dameery, Khloud;
Valsaraj, Blessy Prabha;
Qutishat, Mohammad;
Obeidat, Arwa;
Alkhawaldeh, Abdullah;
Al Sabei, Sulaiman;
Al Omari, Omar;
ALBashtawy, Mohammed;
Al Qadire, Mohammad

Publication type:

Article

Unusual Weight Loss in a Schizophrenic Patient Following Treatment With Aripiprazole: A Case Report.

Published in:

Pharmaceutical & Biomedical Research, 2025, v. 11, n. 1, p. 75, doi. 10.32598/PBR.11.1.1312.2

By:

Asadi, Amir;
Saltili, Mahdi;
Setareh, Javad

Publication type:

Article

Investigating Clozapine-induced Sialorrhea Improvement in Highland Climate Area: A Case Study.

Published in:

Pharmaceutical & Biomedical Research, 2024, v. 10, n. 4, p. 367, doi. 10.32598/PBR.10.4.1312.1

By:

Asadi, Amir;
Salohi, Maluli;
Hosseinl, Seyed Hamzeh

Publication type:

Article

The Acute Onset of Edema Caused by Risperidone in a Schizophrenic Patient: A Case Report.

Published in:

Pharmaceutical & Biomedical Research, 2024, v. 10, n. 3, p. 269, doi. 10.32598/PBR.10.3.1323.1

By:

Ahmadi, Mojtaba;
Hosseini, Seyed Hamzeh

Publication type:

Article

Evaluation of the Pharmacotherapeutic Pattern for Treating Schizophrenia in Bangladesh.

Published in:

Pharmaceutical & Biomedical Research, 2020, v. 6, n. 2, p. 143

By:

Islam, Salsabil;
Sohan, Md.;
Ahmed, Faysal;
Nahar, Zabun;
Islam, Md. Rabiul

Publication type:

Article

Clozapine audit: What do patients and relatives think?

Published in:

Journal of Mental Health, 1996, v. 5, n. 3, p. 267, doi. 10.1080/09638239650036938

By:

Wolfson, Paul Martin;
Paton, Carol

Publication type:

Article

Off-label use of quetiapine.

Published in:

British Journal of Community Nursing, 2023, v. 28, n. 10, p. 476, doi. 10.12968/bjcn.2023.28.10.476

By:

Mendes, Aysha

Publication type:

Article

Invega Hafyera (Paliperidone Palmitate): Extended-Release Injectable Suspension for Patients With Schizophrenia.

Published in:

Journal of Pharmacy Technology, 2023, v. 39, n. 2, p. 88, doi. 10.1177/87551225231153541

By:

Peters, Lindsey;
Dyer, Megan;
Schroeder, Emily;
D'Souza, Manoranjan S.

Publication type:

Article

Cardiovascular Risks of Fluphenazine in a Patient With Schizophrenia.

Published in:

Journal of Pharmacy Technology, 2018, v. 34, n. 4, p. 171, doi. 10.1177/8755122518771269

By:

Burton, Samantha;
Prokop, Matthew;
Kaakeh, Yaman

Publication type:

Article